Jake Leach

speaker

301 appearances 1 recordings 1 series first heard Feb 2026 last heard 19 Feb

Jake Leach’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 1 in all, peaking in Feb 2026 with 1.

Appearances

newest first · ▶ plays the moment

Vanguards of Healthcare by Bloomberg Intelligence · Dexcom Aims to Expand CGM Benefits to All Diabetic Patients and Beyond · 19 Feb 2026 podcast

It's wrapping up here.

We plan to read it out, as you mentioned.

the first half of this year.

And so it will be, we expect it will be an important cornerstone for opening up access for more people with diabetes around the globe, not just here in the US.

These studies that we run here, we've run them in the US, but we use them around the world to grant access.

as the evidence for access for many different countries.

And so this is an important milestone for us and for people with diabetes to generate more access to CGM so they can get the benefits.

Yeah, it's the same metrics, HbA1c, glucose variability dynamics.

We also, though, in all those studies, we also looked at, you know, psychological impact of diabetes and do people feel more confident managing their diabetes when they have a CGM?

And the resounding answer to that is yes, because they have the information they need to be able to understand what's going on and better manage their diabetes and get a better outcome.

And that's really, in the end, this is what this is about, getting technology to people that can benefit.

And so we're really excited about reading this out here that middle year.

So in that study, we are using G7 because we feel that that's the right product for that study.

But in general, as we look at the different platforms, the wearables are very similar.

But when it comes to the software experience, they are different.

And so I see over time that the Stella product will continue to migrate towards prediabetes and health and wellness as G7 takes over the entire diabetes spectrum.

Yeah, one of my initiatives as I stepped into the CEO role January 1st is to expand our international market share.

And we built Dexcom on this leadership in the United States market.

The United States has some of the best coverage for people with diabetes for CGM around the world.

But we are seeing coverage open up in a number of countries.

Showing 181–200 of 301 · page 10 of 16